Haemonetics vs West Pharmaceutical Services
Haemonetics (HAE) and West Pharmaceutical Services (WST) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $5.47B
- Last close
- $120.16
- 12 months
- +60.0%
- Market value
- $28.7B
- Last close
- $390.30
- 12 months
- +51.4%
At a glance
- The biggest part of Haemonetics's revenue is Hospital (44%); at West Pharmaceutical Services it is Proprietary Products (81%).
- Haemonetics earns 74% of its revenue in the United States, West Pharmaceutical Services 43%.
- By market value, West Pharmaceutical Services ($28.7B) is about 5.3 times Haemonetics ($5.5B).
- Over the last 12 months Haemonetics's share price moved +60.0% and West Pharmaceutical Services's +51.4%; against the S&P 500 that is +54.2 points and +45.7 points.
- In their last fiscal years Haemonetics kept 7.3% of revenue as net income and West Pharmaceutical Services 16.1%.
- In the last 90 days insiders reported 0 open-market purchases at Haemonetics and 0 at West Pharmaceutical Services; members of Congress disclosed 0 trades in Haemonetics and 0 in West Pharmaceutical Services.
- Next results: Haemonetics Feb 3, 2027, West Pharmaceutical Services Feb 10, 2027.
How each one makes money: Haemonetics revenue
Share prices on one chart
Haemonetics and West Pharmaceutical Services, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Haemonetics HAENYSE · Health Care Supplies | West Pharmaceutical Services WSTNYSE · Health Care Supplies | |
|---|---|---|
| Size and profitability | ||
| Market value | $5.47B | $28.7B |
| Revenue, last fiscal year | $1.33B | $3.07B |
| Net income, last fiscal year | $97.3M | $494M |
| Net marginNet income as a share of revenue | 7.3% | 16.1% |
| Free cash flow | $260M | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
West Pharmaceutical Services against
Common questions
How is Haemonetics different from West Pharmaceutical Services?
Haemonetics (HAE) is in Health Care Supplies on NYSE, with $1.33B of revenue in its last fiscal year and a net margin of 7.3%. West Pharmaceutical Services (WST) is in Health Care Supplies on NYSE, with $3.07B of revenue in its last fiscal year and a net margin of 16.1%. The biggest part of Haemonetics's revenue is Hospital (44%); at West Pharmaceutical Services it is Proprietary Products (81%). Haemonetics earns 74% of its revenue in the United States, West Pharmaceutical Services 43%. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Haemonetics and West Pharmaceutical Services compare in size?
West Pharmaceutical Services has the larger market value: Haemonetics $5.47B and West Pharmaceutical Services $28.7B, at the last close.
Whose share price rose more over the last 12 months, HAE or WST?
Over the last 12 months Haemonetics moved +60.0% and West Pharmaceutical Services +51.4%. Past price moves say nothing about the future.
Which has had more insider buying, Haemonetics or West Pharmaceutical Services?
Since 2006, Haemonetics insiders reported 142 open-market purchases against 10 for West Pharmaceutical Services. These are counts of what was filed, not a view on either stock.
Do members of Congress trade HAE or WST?
In the last 12 months, members of Congress disclosed 0 trades in Haemonetics (HAE) and 0 in West Pharmaceutical Services (WST).
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Haemonetics pageWest Pharmaceutical Services pageRare insider trades this weekAll comparisons
https://oqro.io/compare/hae-vs-wst



